Hair Restoration Treatment Uses Novel Stem Cell Therapy …

DALLAS UPTOWN and PLANO, Texas, Oct. 10, 2015 /PRNewswire/ -- For men and women who are just beginning to deal with thinning hair, there is a new way to possibly reverse thinning which does not involve tedious follicle-by-follicle transplantation: platelet-rich plasma (P.R.P.), drawn from one's own blood, optimized, and then re-injected into the scalp. P.R.P. contains a large number of adult stem cells, which are known to stimulate cell growth.

A patients' own platelet-rich blood plasma has been utilized in various cosmetic procedures developed over the past several years to encourage the formation of fresh collagen in the face and hands; now, platelet-rich plasma is being micro-injected into the scalp to stimulate renewed, thicker hair growth.

Medical Director Dr. Jeffrey Adelglass and Director of Dermatology Dr. Elizabeth Houshmand of SKINTASTIC Cosmetic Surgery and Laser Skin Care Centers recently added Platelet Rich Plasma Hair Restoration to their already expansive list of face, body, skincare, and wellness services. While P.R.P. hair growth stimulation can be considered somewhat novel, the cellular science behind it has already expanded into a wide range of medical modalities.

Dr. Adelglass explains, "Working with platelet rich plasma, the overall success is very 'donor-dependent.' We carefully screen our prospective PRP patients for medications and other substances known to inhibit the PRP growth factor's ability to 'take,' such as tobacco. Also, P.R.P. therapy is not effective for treating hair roots that are no longer living."

Consultations at SKINTASTIC for P.R.P. Hair Restoration are recommended with Dr. Houshmand, a double board certified dermatologist, to assess whether or not one is a qualified candidate for this procedure. Dr. Houshmand is also an instructor who teaches the technique to other physicians. She briefly explains the procedure: "P.R.P. Hair Growth is an outpatient procedure at SKINTASTIC. Our technician draws a single vial of blood, and we spin it up in the centrifuge to separate the plasma, which is then prepared and immediately micro-injected into the treatment areas. Patients may see their first noticeable hair growth several weeks after their treatment."

Those interested in learning more about P.R.P. Hair Growth Therapy should make an appointment at SKINTASTIC Cosmetic Surgery and Laser Skin Centers in Dallas Uptown or Plano, Texas by calling (972) 620-3223, or at skintastic.com.

Media: Contact Jeffrey Adelglass, M.D., F.A.C.S. at (214) 392-8830, or jeffadel@gmail.comand Elizabeth Houshmand MD FAAD, FABIM at (484) 838-0487 or elizabeth2713@hotmail.com.

Doctors Adelglass or Houshmand may be available for interview on advances in cosmetic surgery and new beauty technologies, or to speak to groups regarding this or other related topics.

SOURCE SKINTASTIC Cosmetic Surgery and Laser Skin Care Centers

RELATED LINKS http://skintastic.com

More:
Hair Restoration Treatment Uses Novel Stem Cell Therapy ...

CD47 – Research and Clinical Trials – Institute for Stem …

The anti-CD47 cancer therapy clinical trials

The clinical trials of the anti-CD47 antibody are underway. As with most FDA phase-1 safety trials, the clinical trial is small and is not currently recruiting additional patients. As the trial progresses, information about the patients in the trial and the data about how the antibody is performing are kept confidential. In accordance with the clinical trial protocol and the policy of the Stanford School of Medicine, we wont be releasing information about the progress of the trial until the data is release by the clinical trials team at the conclusion of the study. Phase-1 clinical trials typically last about 18 months, although this particular trial may be shorter or longer than that.

If and when the clinical trial has openings for additional participants, an announcement will be made on this page. In the meantime, patients can search for currently open trials in the United States through the NIH Clinical Trials Database. Other clinical trials at Stanford can be found here.

CD47 is a kind of protein that is found on the surface of many cells in the body. It tells circulating immune cells called macrophages not to eat these cells. The body uses the CD47 protein to protect cells that should be protected and to help dispose of cells that are aged or diseased. For instance, red blood cells start off with a lot of CD47 on their cell surface when young but slowly lose CD47 as they age. At some point, the amount of CD47 on the surface of an aging red blood cells is not enough to stave off the macrophages, and those older cells are devoured and destroyed, making way for new red blood cells. In this way, the supply of fresh blood cells is constantly replenished.

Unfortunately, some cells that should be destroyed are not. Researchers at Stanford have discovered that nearly every kind of cancer cell has a large amount of CD47 on the cell surface. This protein signal protects the cancer against attack by the body's immune system. Stanford investigators have discovered if that they block the CD47 "don't-eat-me" signal through the use of anti-CD47 antibodies, macrophages will consume and destroy cancer cells. Deadly human cancers have been diminished or eliminated in animal models through the use of anti-CD47 antibody.

News:

Anti-CD47 antibody may offer new route to successful cancer vaccination

Engineered molecules boost immune attack on cancer

See the original post:
CD47 - Research and Clinical Trials - Institute for Stem ...

Stem Cells News — ScienceDaily

Sep. 3, 2015 A number of illnesses causing blindness can be cured from transplanting cells from the oral cavity. New findings make the treatment accessible to the places where the condition strikes the most ... read more Aug. 26, 2015 Compounds found in purple potatoes may help kill colon cancer stem cells and limit the spread of the cancer, according to a team of ... read more Aug. 20, 2015 Scientists have developed a novel way to engineer the growth and expansion of energy-burning 'good' fat, and then found that this fat helped reduce weight gain and lower blood glucose ... read more How Newts Can Help Osteoarthritis Patients Aug. 20, 2015 Osteoarthritis is the most common form of joint disease worldwide. Now, scientists have taken a leaf out of natures book in an attempt to develop effective stem cell treatment for osteoarthritis, ... read more Regenerating Nerve Tissue in Spinal Cord Injuries Aug. 13, 2015 Researchers are exploring a new therapy using stem cells to treat spinal cord injuries within the first 14 to 30 days of injury. The therapy uses a population of cells derived from human embryonic ... read more Newly Discovered Cells Regenerate Liver Tissue Without Forming Tumors Aug. 13, 2015 The mechanisms that allow the liver to repair and regenerate itself have long been a matter of debate. Now researchers have discovered a population of liver cells that are better at regenerating ... read more Aug. 12, 2015 Scientists have discovered metabolic rejuvenation factors in eggs. This critical finding furthers our understanding of how cellular metabolism changes during aging, and during rejuvenation after egg ... read more Can Stem Cells Cause and Cure Cancer? Aug. 12, 2015 Simply put, cancer is caused by mutations to genes within a cell that lead to abnormal cell growth. Finding out what causes that genetic mutation has been the holy grail of medical science for ... read more Why Statins Should Be Viewed as a Double-Edged Sword Aug. 12, 2015 Statins have significant cardiovascular benefits, but also serious side effects. A new study finds that statin use impairs stem cell function, which helps in slowing atherosclerosis but hinders other ... read more Researcher Studying Advances in Next-Generation Stem Cell Culture Technologies Aug. 10, 2015 A researcher is studying ways to advance the next generation of cell culture technologiesthe removal of stem cells from an organism and the controlled growth of those cells in an engineering ... read more Stem Cells Help Researchers Study the Effects of Pollution on Human Health Aug. 10, 2015 Embryonic stem cells could serve as a model to evaluate the physiological effects of environmental pollutants efficiently and cost-effectively. The use of stem cells has found another facade. In the ... read more Aug. 5, 2015 Scientists have, for the first time, found further evidence of how the differentiation of pluripotent cells is tied to and controlled by the cell cycle clock. This deeper understanding of how cells ... read more From Pluripotency to Totipotency Aug. 4, 2015 While it is already possible to obtain in vitro pluripotent cells (i.e., cells capable of generating all tissues of an embryo) from any cell type, researchers have pushed the limits of science even ... read more Precision Medicine Brought One Step Closer to the Clinic Aug. 3, 2015 A revolutionary, high-throughput, robotic platform has been designed that automates and standardizes the process of transforming patient samples into stem cells. This unique platform for the first ... read more Aug. 3, 2015 Investigators report that they have been able to drive cells to grow into muscle fibers, producing millimeter-long muscle fibers capable of contracting in a dish and multiplying in large numbers. ... read more July 30, 2015 Evaluating drug-induced liver injury is a critical part of pharmaceutical drug discovery and must be carried out on human liver cells. Now, scientists report that they produced large amounts of ... read more How a Single Molecule Turns One Immune Cell Into Another July 30, 2015 All it takes is one molecule to reprogram an antibody-producing B cell into a scavenging macrophage. This transformation is possible, new evidence shows, because the molecule (C/EBPa, a transcription ... read more July 29, 2015 A first-of-its kind prostate 'organoid' grown from human embryonic stem cells has enabled researchers to show that exposure to bisphenol A, a chemical in many plastics, can cause ... read more Scientists Identify Gene Vital for Rebuilding Intestine After Cancer Treatment July 29, 2015 A rare type of stem cell is immune to radiation damage thanks to high levels of a gene called Sox9, researchers have ... read more New Drug for Blood Cancers Now in Five Phase II Clinical Trials July 28, 2015 The safety and dosing of a new drug for treating blood cancers has now been established by a group of scientists. The drug is a small molecule inhibitor that suppresses the activity of a signaling ... read more

Go here to read the rest:
Stem Cells News -- ScienceDaily

World Stem Cell Summit

ATLANTA, GEORGIA, USA!

11th World Stem Cell Summit 2nd RegMed Capital Conference Hyatt Regency Atlanta

Collect Opportunities Expand Knowledge Forge Collaborations Deliver Cures

The mandatory, big-picture conference with one-on-one partnering

EXPAND KNOWLEDGE FORGE COLLABORATIONS DELIVER CURES

RegMed Capital Conference

Connecting companies to investors, bringing start-up angel capital and new money into the field. Advancing investment and commercialization, with the overarching purpose of accelerating cures. Investment bankers, analysts, venture groups, angel networks, family funds are attending.

Numerous networking events to make the best connections to advance your goals

7 Tracks- COMPREHENSIVE, TIMELY & DIRECT

ATLANTA, GEORGIA, USA! 11th World Stem Cell Summit 2nd RegMed Capital Conference Hyatt Regency Atlanta

Collect Opportunities Expand Knowledge Forge Collaborations Deliver Cures

Anthony Atala, MD

Wake Forest Institute for Regenerative Medicine

Scott Gottlieb, MD

T.R Winston & Company

Outi Hovatta, MD, PhD

Karolinska Institutet

Paul Knoepfler, PhD

UC Davis School of Medicine

Joanne Kurtzberg, MD

Carolinas Cord Blood Bank at Duke

Jeanne F. Loring, PhD

Center for Regenerative Medicine The Scripps Research Institute

Chris Mason, MBBS, PhD, FRCS

University College London

Michael H. May, PhD

Centre for Commercialization of Regenerative Medicine (CCRM)

Todd C. McDevitt, PhD

Gladstone Institute of Cardiovascular Disease

C. Randal Mills, PhD

California Institute for Regenerative Medicine (CIRM)

Linda Myers

BioBridge Global

Norio Nakatsuji, DSc

Institute for Integrated Cell-Material Science (iCeMS) Kyoto University

Jan A. Nolta, PhD

Stem Cell Program and Institute for Regenerative Cures University of California, Davis

J. Peter Rubin, MD

University of Pittsburgh

Steven L. Stice, PhD

University of Georgia

Susan L. Solomon

New York Stem Cell Foundation

Johnna Temenoff, PhD

Georgia Institute of Technology

Andre Terzic, MD, PhD

Center for Regenerative Medicine Mayo Clinic

Yuzo Toda

FUJIFILM Corporation

Karl Tryggvason, MD, PhD

Karolinska Institutet

Edmund K. Ned Waller, MD, PhD

Emory School of Medicine

Paul Wolpe, PhD

Emory University

Claudia Zylberberg, PhD

Akron Biotechnology, LLC

The 2014 World Stem Cell Summit and REGMED Capital Conference in San Antonio were a bonanza for StemBioSys. As a growing company in the stem cell space, preparing to launch our first product in 2015, the connections and ongoing collaborations that we made at these meetings has already exhibited a multifold return on investment in spreading the word about SBS and uncovering several new opportunities for business and product development.

-Bob Hutchens, President & CEO

Mayo Clinic has embraced regenerative medicine as a strategic investment in the future of healthcare. The World Stem Cell Summit brings together the regenerative medicine community, and sets the stage for global collaboration. Our team at Mayo Clinic is honored to lead it as an organizer again this year.

"The World Stem Cell Summit is a meeting of the stem cell minds, bringing Policy, science, industry, advocates and clinicians together in a unique and powerful forum. The Summit is of great value to researchers by providing a context for stem cell science that is not found at other meetings."

The 2014 World Stem Cell Summit and REGMED Capital Conference in San Antonio were a bonanza for StemBioSys. As a growing company in the stem cell space, preparing to launch our first product in 2015, the connections and ongoing collaborations that we made at these meetings has already exhibited a multifold return on investment in spreading the word about SBS and uncovering several new opportunities for business and product development. We are looking forward to the 2015 meetings in Atlanta.

- Bob Hutchens,President & CEO

Mayo Clinic has embraced regenerative medicine as a strategic investment in the future of healthcare. The World Stem Cell Summit brings together the regenerative medicine community, and sets the stage for global collaboration. Our team at Mayo Clinic is honored to lead it as an organizer again this year.

- Dr. Andre Terzic

The World Stem Cell Summit is a meeting of the stem cell minds, bringing Policy, science, industry, advocates and clinicians together in a unique and powerful forum. The Summit is of great value to researchers by providing a context for stem cell science that is not found at other meetings.

- Sally Temple,Ph.D.

The World Stem Cell Summit and the RegMed Capital Conference offers a number of key opportunities to advance progress for sponsors, exhibitors, and advertisers of all sizes, while we collectively support the advancement of the field.

Request a sponsorship kit today.

More here:
World Stem Cell Summit

New measurements reveal differences between stem cells for …

By growing two types of stem cells in a "3-D culture" and measuring their ability to produce retinal cells, a team lead by St. Jude Children's Research Hospital researchers has found one cell type to be better at producing retinal cells.

The research not only reveals which stem cell type might be better for treating retinal degeneration, but it also demonstrates a standardized method for quantifying the effectiveness of different stem cells for such therapies.

The research was led by Michael Dyer, Ph.D., a member of the St. Jude Department of Developmental Neurobiology and a Howard Hughes Medical Institute investigator. The findings were published in the July 2 edition of the journal Cell Stem Cell.

Stem cells are immature cells that can differentiate into more specialized cells in the body. In early clinical trials, researchers are testing whether stem cells can be differentiated into cells to replace those that are defective and die off in diseases such as age-related macular degeneration, retinitis pigmentosa and Stargardt's disease. Such degeneration is the leading cause of vision loss, affecting more than 10 million people in the U.S.more than cataracts and glaucoma combined.

While such clinical trials have shown early promise, there are many scientific questions to be answered. "One important question is whether it makes a difference where the stem cells come from," Dyer said. "Our research sought to explore that question and also to learn more about the biology of these stem cells."

The researchers compared two types of stem cells called "induced pluripotent stem cells," which can be generated from adult cells. The stem cells they compared were fibroblast-derived cells generated from skin, and those generated from mature eye cells called rod photoreceptor cells.

Scientists previously thought that induced pluripotent stem cells could not be made from adult neurons without introducing a mutation that switches off a key regulatory gene called p53. Dyer's lab developed a new method for making stem cells from neurons that did not require p53 inactivation. This 3-D culture technique involved surrounding the neurons undergoing reprogramming with normal retinal neurons, to create a more natural environment for producing stem cells from neurons. This technique contrasts with the more common culture technique of growing the cells in layers on culture dishes, which is not successful for such cells. Once the stem cells are produced, they can then be used to make retinal cells in 3-D cultures.

Besides the 3-D culture technique, the researchers also used a set of measurements, called STEM-RET, which enabled them to quantify precisely how successful different retinal cells are in generating retinal cells. Their STEM-RET analysis revealed that the rod-derived stem cells produced more retinal cells than did the fibroblast stem cells. The fibroblast-derived retinal cells were missing some cell types needed for fully functional retinas.

Dyer and his colleagues also explored the biological differences in the two stem cell types that could explain their differences in producing retinal cells. Specifically, the researchers analyzed differences in the epigenetic control machinery of the two types. Such epigenetic machinery of cells consists of biological switches that control the cell's genes. These are distinct from the genetic control machinery built into the DNA structure of the cell's genes themselves.

Scientists believe that different stem cell types may retain an "epigenetic memory"a distinctive set of epigenetic switches, even as they are reprogrammed from mature cell types. This "memory" affects how well the stem cells produce different cell types.

See original here:
New measurements reveal differences between stem cells for ...

Stem cell expert: Bart Starr treatment shows need for …

The news that legendary Green Bay Packer quarterback Bart Starr has undergone stem cell therapy to recover from a stroke has raised the profile for a promising but unproven regenerative treatment intended to replace dead neurons with live ones.

The University of Wisconsin-Madison's Su-Chun Zhang was the first scientist to isolate neural stem cells from embryonic stem cells and then from other types of all-purpose stem cells. He says medical researchers and the federal government have a responsibility to forge ahead with clinical trials to prove whether and how these flexible cells can replace damaged or dead neural cells caused by spinal cord injury, stroke and Lou Gehrig's disease (ALS).

Su-Chun Zhang

"We have no effective treatment for stroke," says Zhang, a medical doctor and Ph.D. researcher at the UW's Waisman Center. "After a couple of hours, the cells are dead if they don't have a blood supply. And the brain has a very limited capacity to regenerate, particularly in older patients."

Embryonic stem cells the cells that give rise to all body tissues were first cultured by James Thomson at UW-Madison in 1998. Just three years later in 2001 Zhang discovered how to grow neural cells from embryonic stem cells.

Since then, he has been instrumental in differentiating these neural cells into neurons, which carry nerve signals, and glial cells, which keep neurons healthy. UW-Madison currently has more than 90 faculty working on the basic science and regenerative potential of stem cells. UW scientists publish more than 500 research articles each year on stem cells.

Zhang expressed hope that Starr will recover, but says there are plenty of question marks, such as what type of cells were used, and how they were inserted into the body.

In a statement Wednesday, Starr's family announced he was participating in a stem-cell trial but gave no details of how or where he was being treated. Published reports have said that the family received information about stem-cell treatment in Tijuana, Mexico, undergone by hockey Hall-of-Famer Gordie Howe.

The Food and Drug Administration has been more conservative than some foreign regulators, Zhang says, but science has advanced to the point where human trials are justified, especially for untreatable conditions.

View original post here:
Stem cell expert: Bart Starr treatment shows need for ...

Encapsulated stem cells accelerate wound healing

Mesenchymal stem cells captured in microcapsules. Each microcapsule is roughly 40 micrometers across.

A team of Cornell scientists has shown that stem cells confined inside tiny capsules secrete substances that help heal simulated wounds in cell cultures, opening up new ways of delivering these substances to locations in the body where they can hasten healing.

The capsules need to be tested to see if they help healing in animals and humans, but they could eventually lead to living bandage technologies: wound dressings embedded with capsules of stem cells to help the wound regenerate.

Microencapsulated equine mesenchymal stromal cells promote cutaneous wound healing in vitro appeared in the April 10Stem Cell Research & Therapy.

The encapsulation seems to increase the stem cells regenerative potential, said Gerlinde Van de Walle of the Baker Institute for Animal Health in the College of Veterinary Medicine, adding that the reasons why are not yet known. It's possible that putting them in capsules changes the interactions between stem cells or changes the microenvironment.

To her knowledge, Van de Walle said, this is the first time encapsulated stem cells have been used to treat wounds. Her team used horse stem cells and cell cultures because, unlike mice, the healing process in horses shares important similarities with the healing process in humans and because wound healing in horses is a particularly difficult problem in veterinary medicine.

Mesenchymal stem cells are adult stem cells that can be isolated from different parts of the body, and its long been known that they secrete substances that aid in tissue healing. Problems arise when trying to use these stem cells in real patients, Van de Walle said, because they often wont stay put in the healing area and can occasionally form tumors or develop into unwanted cell types. She and her team began exploring the possibilities of encapsulating these cells as a way of avoiding these pitfalls. The capsules help cells stay in place while they secrete substances into the wound and can be removed easily if the stem cells would develop in an adverse way.

The researchers collaborated with Mingling Ma of the Department of Biological and Environmental Engineering and his laboratory to create the coreshell hydrogel microcapsules around the stem cells

Van de Walle says she was excited to see that the capsules did not abolish the stem cell properties but instead appeared to enhance the beneficial effects the stem cell secreted products have on tissue cultures. This suggests that encapsulating the stem cells for wound healing not only avoids certain problems, it can boost the effectiveness of treatment.

With their mesenchymal stem cell work, Van de Walle and her colleagues are trying to understand the basic science behind the regenerative abilities of these cells.

See the original post:
Encapsulated stem cells accelerate wound healing

One type of lung cell can regenerate as another type of lung cell, study finds

April 13, 2015

Adult lung cells regenerating: Type 1 cells are green. Type 2 cells are red. New Type 2 derived from Type 1 cells are yellow. Nuclei are blue. (Credit: Jon Epstein, MD & Rajan Jain, MD, Perelman School of Medicine at the University of Pennsylvania, and Christina Barkauskas & Brigid Hogan, Duke University)

Brett Smith for redOrbit.com @ParkstBrett

When we think of tissue regeneration, we typically think of stem cells and their capacity to develop into a wide range of different cell types.

However, a team of scientists from Duke University and the University of Pennsylvania have shown that certain cells in the lungs are able to give rise to other lung cell types, according to a new study in the journal Nature Communications.

Its as if the lung cells can regenerate from one another as needed to repair missing tissue, suggesting that there is much more flexibility in the system than we have previously appreciated, said study author Dr. Jon Epstein, chair of the department of Cell and Developmental Biology at Penn. These arent classic stem cells that we see regenerating the lung. They are mature lung cells that awaken in response to injury.

We want to learn how the lung regenerates so that we can stimulate the process in situations where it is insufficient, such as in patients with COPD (chronic obstructive pulmonary disease), he added.

A mind of its own

There are two types of cells in the air sacs of the lung known as alveoli. Long, slender Type 1 cells are where inhaled gases are exchanged. Type 2 cells release surfactant, a soapy compound that assists in keeping airways open. Sometimes, premature babies need to be given surfactant to assist them with breathing.

In the study, the team used mouse models to find that both of these kinds of cells are derived from a standard precursor stem cell in the embryo. Next, the researchers used other mouse models involving part of the lung that was removed for cell cultures to examine the plasticity of cell types throughout lung regeneration. The team saw that Type 1 cells can give rise to Type 2 cells, and vice-versa.

Originally posted here:
One type of lung cell can regenerate as another type of lung cell, study finds

Dr. Raj, Top Beverly Hills Orthopedic Doctor, Appears on The Doctors TV Show Performing Successful Stem Cell Therapy

Beverly Hills, California (PRWEB) April 13, 2015

Dr. Raj, who is the top orthopedic surgeon in Los Angeles and Beverly Hills, appeared on The Doctors TV show this week performing successful stem cell therapy. The patient received an outpatient stem cell procedure for bilateral labral tears in the shoulders, with an incredible outcome displayed on the show.

The segment can be viewed here: http://www.thedoctorstv.com/videos/stem-cells-instead-of-surgery

For years, Dr. Raj has been helping patients avoid invasive surgeries with outpatient, low risk stem cell procedures. The focus of the segment on The Doctors was a patient who was having severe functional limitations due to her shoulder injuries. She could not drive without pain or do any regular activities such as brushing her hair or reaching overhead without immediate pain.

While being interviewed on the show four days after the procedure, Jennifer stated, "This is crazy. What's really shocking is I can put my arms above my head, I haven't done that in 10 years!"

Dr. Raj, as he has done for hundreds of patients, first aspirated some of the patients bone marrow. Then the marrow was processed immediately to concentrate the stem cells and growth factors. The processed marrow was then injected bilaterally into her shoulders along with numbing medicine, and then the procedure was done.

After four days the patient appeared with Dr. Raj on the show. She was able to painlessly drive, lift her arms above her head, and was truly amazed at the outcome in such a short time. Dr. Raj was asked if her result was typical.

He replied, "Stem cells are so magical. I've seen this frequently, it is expected."

Host Dr. Travis Stork then said, "I'm a fan if you can avoid a true surgery. It's all about the beauty of more options. This just adds another option in the arsenal."

For over 5 years, Dr. Raj has been named a Top Doctor in Southern California, Beverly Hills, Los Angeles and Nationally as well. He serves as an ABC News Medical Correspondent as well as a WebMD expert. National newspapers and television networks often turn to Dr. Raj for perspective on orthopedic injuries and treatments.

More here:
Dr. Raj, Top Beverly Hills Orthopedic Doctor, Appears on The Doctors TV Show Performing Successful Stem Cell Therapy

Sungduan: Age-defying

AGING is inevitable. But why worry about getting old in looks when you can defy it?

With todays latest technology, one can now become younger from 10-20 years old and achieve a celebrity look without surgery in just a few months. This is through the stem cell technology found in facial cream and unique dietary supplements.

According to Dr. Marc Lavaro Jr., an expert on general & ocular oncology, general & ocular

pharmacology, pediatric ophthalmic medicine, and Science of Epigenetics, the stem cell technology is not only a cure for some diseases such as cancer but also answers beauty concerns like fine facial lines and wrinkles.

He said this new technology, which is considered as a breakthrough can now be found in Jeunesse, a product of medical research conducted by Dr. Nathan Newman, the father of stem cell technology.

Newman is also world renowned for his cosmetic surgery and being innovator of stem cell lift cutting edge cosmetic surgery.

Stem cell repairs and rejuvenates at babalik sa normal ang good looks. Those who are bald can have their hair back as well, Lavaro said.

Getting rid of facial lines and wrinkles may be done through the use of two technologies. One is temporary and the other is permanent.

The temporary has the Cinderella effect wherein in just 2 minutes you will be wrinkle and eyebags free.

For the permanent, the maximum ideal effect can be seen after 30 days. The outcome of this using the Luminesce which serves as a lifting mask has the eight-times effect.

Read more:
Sungduan: Age-defying